It was also shown that serum IGF-I was elevated in CLL patients, but the level of GH remained unchanged, suggesting that autocrine production of IGF-I by CLL cells results in increased levels of serum IGF-I, independently of GH, and can stimulate IGF-IR to promote CLL cell survival. This evidence concerns the gene IGF1R and B-cell chronic lymphocytic leukemia.